TIMER2.0 was applied to study the mRNA expression levels of CDC42 for the entire 33 tumors in the TCGA database to explore the difference in CDC42 expression between tumors and adjacent tumor-free tissues. This evidence concerns the gene CDC42 and neoplasm.